United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Buys 28,839 Shares of Zoetis Inc. (NYSE:ZTS)

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 19.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 180,637 shares of the company's stock after acquiring an additional 28,839 shares during the period. Zoetis makes up approximately 1.8% of United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's portfolio, making the stock its 23rd largest position. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund's holdings in Zoetis were worth $35,652,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in ZTS. Enterprise Financial Services Corp raised its holdings in shares of Zoetis by 2.3% during the first quarter. Enterprise Financial Services Corp now owns 2,446 shares of the company's stock valued at $407,000 after purchasing an additional 55 shares during the last quarter. CreativeOne Wealth LLC lifted its holdings in Zoetis by 0.4% in the second quarter. CreativeOne Wealth LLC now owns 12,833 shares of the company's stock valued at $2,210,000 after acquiring an additional 57 shares during the period. River Street Advisors LLC boosted its position in Zoetis by 3.4% in the fourth quarter. River Street Advisors LLC now owns 1,757 shares of the company's stock worth $347,000 after purchasing an additional 58 shares during the last quarter. Perigon Wealth Management LLC grew its stake in shares of Zoetis by 0.3% during the 4th quarter. Perigon Wealth Management LLC now owns 23,581 shares of the company's stock valued at $4,654,000 after purchasing an additional 59 shares during the period. Finally, TFC Financial Management Inc. grew its stake in shares of Zoetis by 3.3% during the 3rd quarter. TFC Financial Management Inc. now owns 1,918 shares of the company's stock valued at $334,000 after purchasing an additional 61 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.


Insiders Place Their Bets

In other news, EVP Roxanne Lagano sold 923 shares of the firm's stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $173.33, for a total value of $159,983.59. Following the sale, the executive vice president now directly owns 15,723 shares in the company, valued at approximately $2,725,267.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 2,209 shares of company stock worth $408,453 over the last 90 days. Company insiders own 0.15% of the company's stock.

Zoetis Trading Down 0.7 %

Shares of NYSE ZTS traded down $1.08 during midday trading on Wednesday, hitting $151.94. The company's stock had a trading volume of 3,258,747 shares, compared to its average volume of 2,965,319. Zoetis Inc. has a 12-month low of $148.48 and a 12-month high of $201.92. The company has a current ratio of 3.36, a quick ratio of 2.00 and a debt-to-equity ratio of 1.32. The firm has a market cap of $69.49 billion, a P/E ratio of 30.18, a price-to-earnings-growth ratio of 2.29 and a beta of 0.85. The business's 50 day moving average is $178.25 and its two-hundred day moving average is $180.59.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share for the quarter, missing the consensus estimate of $1.32 by ($0.08). The company had revenue of $2.21 billion for the quarter, compared to the consensus estimate of $2.19 billion. Zoetis had a net margin of 27.43% and a return on equity of 51.25%. The business's revenue was up 8.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.15 EPS. As a group, equities research analysts expect that Zoetis Inc. will post 5.8 EPS for the current year.

Zoetis Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 4th. Stockholders of record on Friday, April 19th will be issued a $0.432 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $1.73 annualized dividend and a dividend yield of 1.14%. Zoetis's dividend payout ratio is currently 34.12%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. StockNews.com downgraded Zoetis from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, February 20th. Stifel Nicolaus decreased their price target on Zoetis from $215.00 to $195.00 and set a "buy" rating on the stock in a report on Tuesday, April 2nd. Piper Sandler reaffirmed an "overweight" rating and issued a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research note on Tuesday. The Goldman Sachs Group boosted their price target on Zoetis from $190.00 to $226.00 and gave the stock a "buy" rating in a report on Wednesday, January 17th. Finally, Barclays increased their price objective on shares of Zoetis from $255.00 to $260.00 and gave the company an "overweight" rating in a report on Wednesday, February 14th. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of "Buy" and an average target price of $221.75.

View Our Latest Research Report on ZTS

Zoetis Profile

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Featured Stories

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Should you invest $1,000 in Zoetis right now?

Before you consider Zoetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.

While Zoetis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: